ArticleJournal of experimental & clinical cancer research : CR2018

HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.